December Purchasing Managers Index Points to Slower Growth
For those who were hoping for 4% growth in gross domestic product to continue late in 2018 and into 2019, the first economic release of 2019 might continue to temper expectations.
All Work
Jon C. Ogg
Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000
See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average in 2019.
Meet the 2019 Dogs of the Dow
Investors love their dividends. So 24/7 Wall St. has tracked the Dogs of the Dow strategy for years now.
15 Top IPOs to Watch For in 2019
24/7 Wall St. has compiled a list of companies likely be on the IPO docket for 2019, including Uber, SpaceX and GE Healthcare.
Top Analyst Upgrades and Downgrades: Atmos Energy, CRISPR Therapeutics, CSX, Editas, Mallinckrodt, Microsoft, Sun Life, Ultragenyx and More
The top analyst upgrades, downgrades and initiations seen on the last trading day of 2018 include Atmos Energy, CRISPR Therapeutics, CSX, Editas, Mallinckrodt, Microsoft, Sun Life and Ultragenyx.
10 ETFs to Avoid a Stock Market Crash in 2019, or Even Profit From It!
These 10 exchange-traded funds can help even the smallest of retail investors avoid losing their shirts, or even make a profit, during uncertainty in the next major sell-off or stock market crash.
Altria’s Diversification Into Vaping and Cannabis May Have Too High a Cost
Diversification is supposed to be a good thing. But at what price is another issue entirely, as seen in Altria on Thursday.
Philly Fed Continues Weaker Growth Trends, Identifies Price Hike Expectations for 2019
The Federal Reserve Bank of Philadelphia has reported that manufacturing activity in its region has continued to grow but at a subdued pace in December.
Top Analyst Upgrades and Downgrades: Apple, Arconic, Chipotle, GrubHub, Halliburton, Humana, Yelp and Many More
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Arconic, Chipotle Mexican Grill, GrubHub, Halliburton, Humana and Yelp.
FOMC Verdict: A Less-Hawkish Jerome Powell Is Not Dovish
Wednesday, December 18, 2018 was a day that could have marked a turning point for the Federal Reserve and Fed Chairman Jerome Powell in the quest to raise interest rates. After having fed…
Significant Amex Downgrade Points to Macro Headwinds Ahead After Strong Outperformance
American Express just took a big analyst downgrade from Merrill Lynch. The big issue is that the macro (economic) story outweighs the micro for now.
Analysts Still Have Not Capitulated on Micron
Micron Technology was trounced after earnings and guidance disappointed investors. Yet there does not seem to be a true capitulation among the analyst community.
Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Baker Hughes, Biogen, FedEx, Intel, Micron Technology, Roku and Shake Shack.
Credit Suisse Has 6 Top Solar Stock Picks for 2019
Credit Suisse has issued an alternative energy outlook for 2019. It should be easy to understand what the bias is here when you see the title of the report.
With Shares Now Under $1, Will Blue Apron Be Kicked Off the NYSE?
Blue Apron technically joined the realm of penny stocks during this latest downdraft in the markets. If its shares stay under a dollar for too long, it could face delisting from the New York…
Goldman Sachs Predicts Slower Information Technology Spending Growth in 2019
Many investors have been hoping that the information technology sector will hold up in 2019, but Goldman Sachs believes that IT spending will see slower growth in 2019.
Credit Suisse 2019 Medical Devices Outlook Looks Very Bullish, Even Out to 2025
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
Credit Suisse Trims S&P 500 Target for 2019 but Sees Upside in Stock Market Outlook
One of the most bullish Wall Street firms for 2019 just decided that the recent market volatility was reason enough to lower its S&P 500 price target for 2019.
Boeing and J&J Both Offer New Incentives for Investors After Big Losses
These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.